Gene Editing: How CRISPR Will Change EVERYTHING & Create Designer Babies
Valuetainment
Valuetainment Episodes
4.8 • 1.7K Ratings
🗓️ 20 December 2023
⏱️ 11 minutes
🧾️ Download transcript
Summary
Patrick Bet-David explains why the FDA has officially approved CRISPR gene editing as a treatment for Sickle Cell Disease, marking a historic milestone in medical science. The science behind CRISPR-Cas9, a revolutionary gene-editing tool has transformed biomedical research. Understand how it can precisely alter DNA to correct genetic defects, potentially treating a range of illnesses. As CRISPR technology advances, so does the debate over its ethical use. PBD also discusses the controversial topic of designer babies, examining the moral implications and potential societal impacts of gene editing for non-therapeutic purposes. Connect one-on-one with the right expert to get the answers you need with Minnect: https://bit.ly/3MC9IXE Get best-in-class business advice with Bet-David Consulting: https://bit.ly/40oUafz Visit VT.com for the latest news and insights from the world of politics, business and entertainment: https://bit.ly/472R3Mz Visit Valuetainment University for the best courses online for entrepreneurs: https://bit.ly/47gKVA0 Text “PODCAST” to 310-340-1132 to get the latest updates in real-time! SUBSCRIBE TO: @VALUETAINMENT @PBDPodcast @ValuetainmentShortClips @vtsoscast @VALUETAINMENTRUSSIAN @ValuetainmentComedy @bizdocpodcast @BrandonAceto @theunusualsuspectspodcast @kvoncomedy Want to be clear on your next 5 business moves? https://bit.ly/3Qzrj3m Join the channel to get exclusive access to perks: https://bit.ly/3Q9rSQL Download the podcasts on all your favorite platforms https://bit.ly/3sFAW4N Patrick Bet-David is the founder and CEO of Valuetainment Media. He is the author of the #1 Wall Street Journal Bestseller “Your Next Five Moves” (Simon & Schuster) and a father of 2 boys and 2 girls. He currently resides in Ft. Lauderdale, Florida.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | How much are you following what's going on with gene editing with this company called CRISPR that just got this new approval by the FDA on December 8, 2023, |
| 0:08.0 | CRISPR gene editing drug for sickle cell disease has officially been approved. |
| 0:12.0 | So imagine what this soul gene editing means. |
| 0:14.0 | Let's just say, you know how nowadays people say, I don't want to just have one baby, I just want to do it once and I want to have three babies. You couldn't do that before. |
| 0:21.0 | That's normal now. What if you can go to the doctor and you say, okay |
| 0:24.4 | Doc here's the menu what would you like? I want him to be six five. No no |
| 0:29.2 | babe that's too tall six three and a half. He's gonna be six three and a half. What color eyes you want |
| 0:33.9 | him to have? Green eyes. Green eyes it is. How big arms do you want? |
| 0:37.8 | What? How about shoe size? I'd like him to end up having 13 and a half show. |
| 0:41.2 | Oh that's exactly what he's gone. How about hair? |
| 0:43.2 | No not blonde list. Can you imagine if you could do that? By the way, that's the direction |
| 0:46.8 | we're going. This company, CRISPR, gets started in 2013. Goes public in 2016. |
| 0:51.0 | Becomes almost a $200 share company. right now it's around $60 to $68 |
| 0:55.0 | give or take four and a half billion dollar company and while you're listening to |
| 0:58.1 | this and you're saying Pat this is craziness there's no way we're going this direction |
| 1:02.3 | well apparently CRISPR can craziness. There's no way we're going this direction. Well, |
| 1:02.8 | apparently CRISPR can cure cancer, blood disorders, blindness, AIDS, |
| 1:08.6 | cystic fibrosis, muscular dystrophy, Huntington Disease, and COVID-19. |
| 1:14.0 | And by the way, you want to know a little weird thing, |
| 1:15.8 | what's going on with China? |
| 1:16.8 | In 2020, a US intelligence report showed that China |
| 1:20.5 | conducted human testing on members of the People's Liberation Army, PLA, in hope of developing |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Valuetainment Episodes, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Valuetainment Episodes and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.